Search research articles
Contact Us
Filters
Showing results (81-90 of 95) with videos related to
Page
of 10
Sort By:
Acta Oncologica (Stockholm, Sweden)
|
October 10, 2023
Clinical outcomes of <i>ALK</i>+ non-small cell lung cancer in Denmark
Karin Holmskov Hansen, Jakob Sidenius Johansen, Edyta Maria Urbanska, et al.
Oncotarget
|
September 18, 2018
Circulating tumor DNA as a marker of treatment response in BRAF V600E mutated non-melanoma solid tumors
Lise Barlebo Ahlborn, Ida Viller Tuxen, Florent Mouliere, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 3, 2018
Copenhagen Prospective Personalized Oncology (CoPPO)-Clinical Utility of Using Molecular Profiling to Select Patients to Phase I Trials
Ida Viller Tuxen, Kristoffer Staal Rohrberg, Olga Oestrup, et al.
NPJ Genomic Medicine
|
July 3, 2019
High frequency of pathogenic germline variants within homologous recombination repair in patients with advanced cancer
Birgitte Bertelsen, Ida Viller Tuxen, Christina Westmose Yde, et al.
Cancer Research Communications
|
December 10, 2025
Targeting uPARAP with an antibody-drug conjugate exhibits efficacy against mesothelioma and synergizes with cisplatin
Pınar Çakılkaya, Ida Marie Egeland Larsen, Qun Jiang, et al.
BMC Cancer
|
August 7, 2025
Mutational Landscape Assessed in Tumor Tissue and Circulating Tumor DNA During Treatment of Patients with HER2/ERBB2-Mutated Solid Tumors
Kristian Egebjerg, Iben Spanggaard, Lise Barlebo Ahlborn, et al.
Frontiers in Bioengineering and Biotechnology
|
April 20, 2026
Histological fidelity and microenvironmental kinome signatures of metastatic patient-derived organoids
Joana Leitão-Castro, Alexia Melanie Lopresti, Kamilla Westarp Zornhagen, et al.
Molecular Cancer Therapeutics
|
July 16, 2025
The recycling collagen receptor uPARAP is a unique mediator of stromal drug delivery to carcinoma cells
Kirstine S Nørregaard, Ida M E Larsen, Henrik J Jürgensen, et al.
Lung Cancer Management
|
May 31, 2024
Lung cancer patients with anaplastic lymphoma kinase rearrangement lose affiliation with labor market at diagnosis
Jon Lykkegaard Andersen, Jakob Sidenius Johansen, Edyta Maria Urbanska, et al.
Cancer Research
|
April 30, 2011
MMSET is highly expressed and associated with aggressiveness in neuroblastoma
Heidi Rye Hudlebusch, Julie Skotte, Eric Santoni-Rugiu, et al.
Page
of 10
Search research articles
Search
Showing results (81-90 of 95) with videos related to
Sort By:
Page
of 10
Acta Oncologica (Stockholm, Sweden)
|
October 10, 2023
Clinical outcomes of <i>ALK</i>+ non-small cell lung cancer in Denmark
Karin Holmskov Hansen, Jakob Sidenius Johansen, Edyta Maria Urbanska, et al.
Oncotarget
|
September 18, 2018
Circulating tumor DNA as a marker of treatment response in BRAF V600E mutated non-melanoma solid tumors
Lise Barlebo Ahlborn, Ida Viller Tuxen, Florent Mouliere, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 3, 2018
Copenhagen Prospective Personalized Oncology (CoPPO)-Clinical Utility of Using Molecular Profiling to Select Patients to Phase I Trials
Ida Viller Tuxen, Kristoffer Staal Rohrberg, Olga Oestrup, et al.
NPJ Genomic Medicine
|
July 3, 2019
High frequency of pathogenic germline variants within homologous recombination repair in patients with advanced cancer
Birgitte Bertelsen, Ida Viller Tuxen, Christina Westmose Yde, et al.
Cancer Research Communications
|
December 10, 2025
Targeting uPARAP with an antibody-drug conjugate exhibits efficacy against mesothelioma and synergizes with cisplatin
Pınar Çakılkaya, Ida Marie Egeland Larsen, Qun Jiang, et al.
BMC Cancer
|
August 7, 2025
Mutational Landscape Assessed in Tumor Tissue and Circulating Tumor DNA During Treatment of Patients with HER2/ERBB2-Mutated Solid Tumors
Kristian Egebjerg, Iben Spanggaard, Lise Barlebo Ahlborn, et al.
Frontiers in Bioengineering and Biotechnology
|
April 20, 2026
Histological fidelity and microenvironmental kinome signatures of metastatic patient-derived organoids
Joana Leitão-Castro, Alexia Melanie Lopresti, Kamilla Westarp Zornhagen, et al.
Molecular Cancer Therapeutics
|
July 16, 2025
The recycling collagen receptor uPARAP is a unique mediator of stromal drug delivery to carcinoma cells
Kirstine S Nørregaard, Ida M E Larsen, Henrik J Jürgensen, et al.
Lung Cancer Management
|
May 31, 2024
Lung cancer patients with anaplastic lymphoma kinase rearrangement lose affiliation with labor market at diagnosis
Jon Lykkegaard Andersen, Jakob Sidenius Johansen, Edyta Maria Urbanska, et al.
Cancer Research
|
April 30, 2011
MMSET is highly expressed and associated with aggressiveness in neuroblastoma
Heidi Rye Hudlebusch, Julie Skotte, Eric Santoni-Rugiu, et al.
Page
of 10